Dr. Robert E. Brannigan, MD

Dr. Brannigan practices at Northwestern Medical Group in Chicago, Illinois.

Dr. Brannigan's NPI, 1073573143, was assigned on March 24, 2006. Dr. Brannigan graduated from Feinberg School of Medicine in 1992. Dr. Brannigan holds Illinois license 036090931.

Dr. Brannigan's primary practice is Northwestern Medical Group, at 675 N Saint Clair St Ste 19-100 Suite 19-100, Chicago, IL 60611. The practice phone is (312) 664-3278.

Dr. Brannigan's primary practice is Northwestern Medical Group in Chicago, Illinois. Dr. Brannigan is also affiliated with Northwestern Memorial Hospital. The medical group on file is Northwestern Medical Faculty Foundation. Dmand AI also links Dr. Brannigan to 3 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Brannigan practices, 5 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Brannigan's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Brannigan is board certified in urology by the American Board of Urology. Dmand AI has Dr. Brannigan's licenses on file in 8 states: Illinois, Arizona, Iowa, Tennessee, Indiana, Kentucky, Texas and Wisconsin.

Dmand AI lists enlarged prostate, erectile dysfunction, kidney cysts, testicular dysfunction, urinary endoscopy, urine flow blockage and UTI among the conditions Dr. Brannigan treats.

CMS data shows 105 Medicare services from Dr. Brannigan across 2 procedure codes in 2024, for 117 Medicare patients. Medicare paid $7,880 for them. Every service was in an office.

CMS counts 117 Medicare patients who saw Dr. Brannigan in 2024. The largest group is 65 to 74, with 56 patients. 75% of them have high cholesterol, and 63% have high blood pressure. 15% are also on Medicaid. Their average risk score is 1.49, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Brannigan's median patient age at 41, with 1% women.

In 2024, Dr. Brannigan wrote 114 Medicare Part D claims for 50 patients. 97% of them were for generic drugs. CMS names the drug for 57 of them, across 3 drugs with 11 or more claims each, at $7,098 in total drug cost. In 2023, CMS named 74 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Brannigan for performance year 2024, reported through an alternative payment model (APM). Dr. Brannigan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Brannigan as offering telehealth.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 150 papers to Dr. Brannigan, published from 2007 to 2025. 2020 was the busiest year, with 15. The most frequent topics are Infertility, Male, Testosterone and Hypogonadism. Dr. Brannigan has published most often in Fertil Steril. Dr. Brannigan's most frequent co-authors are Nelson E. Bennett, MD, Matthew Hudnall, MD and Jeremy D. Lai, MD.

CMS Open Payments shows 6 general payments to Dr. Brannigan from 5 drug and device companies from 2016 to 2022. Food and beverage make up the largest share, 100% of the total. Boston Scientific Corporation paid the most, $141.

Dmand AI lists 1 award for Dr. Brannigan, most recently CMS Stage 1 2012 in 2011.

Dr. Brannigan graduated from Feinberg School of Medicine in 1992.

Dr. Brannigan is in network with 14 carriers, including Aetna, Excellus BlueCross BlueShield and HCSC. HMO plans come from the most carriers, 10. Check the plan with the practice before a visit.